News and Press Releases
Press releases
Theralase Increases Revenue 14% in 3Q2016
Toronto, Ontario – November 29, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biot...
0Theralase Announces Completion of Public Offering of Units
Not for distribution to U.S. news wire services or dissemination in the United States. Toronto, Ontario – November 10, 2016 – Theralase Technolo...
0Theralase Announces Proposed Public Offering of Units
Not for distribution to U.S. news wire services or dissemination in the United States. Toronto, Ontario – November 7, 2016, Theralase Technolog...
0Theralase Announces Filing of Amended and Restated Financial Statements for the Quarter Ended June 30, 2016
Toronto, Ontario – November 3, 2016 – Theralase Technologies Inc. (“Theralase” or the “Corporation”) (TLT:TSXV) (TLTFF:OTC), a leading bi...
0Theralase Provides Clarification Regarding Certain Forward-Looking Information
Toronto, Ontario – November 1, 2016 – Theralase Technologies Inc. (“Theralase” or the “Corporation”) (TLT:TSXV) (TLTFF:OTC), a leading bi...
0Theralase Increases GBM Brain Cancer Survival by 925%
Toronto, Ontario – October 28, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Anti-Cancer Technology to be Presented at International Conference
Toronto, Ontario – October 25, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading bi...
0Health Canada Grants Theralase ITA Approval
Toronto, Ontario – October 20, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Demonstrates Significant Increase in Survival for Brain Cancer
Toronto, Ontario – October 13, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biote...
0Theralase Provides Update on ITA Application to Health Canada
Toronto, Ontario – October 5, 2016, Theralase Technologies Inc. (“Theralase®” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotec...
0in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.